In vitro study of lysozyme in poly(lactide-co-glycolide) microspheres with SUCROSE ACETATE ISOBUTYRATE (cas 126-13-6)

Add time:09/24/2019    Source:sciencedirect.com

This study investigated the suitability of microsphere formulations for extended protein delivery and complete protein release. These microspheres were prepared by a multi-emulsion method and prepared using a mixture of poly(lactide-co-glycolide) (PLGA), RG 502H (lactide:glycolide = 50:50, MW 9300) and sucrose acetate isobutyrate (SAIB). SAIB embedded into the microspheres and mixed with PLGA, improved the efficiency of enzyme encapsulation. The in vitro release rate of lysozyme (Lys) from the microspheres was reduced due to the high viscosity of the added SAIB and less degradation of PLGA by SAIB. These properties enabled prolonged release of Lys for up to 2 months, characterized by a minimal initial burst of Lys and nearly zero-order protein release kinetics result from co-administration of sorbitan monooleate 80. When it is considered that degradation products of SAIB are inactive for labile proteins, SAIB may be regarded as a promising candidate for long-acting protein delivery.

We also recommend Trading Suppliers and Manufacturers of SUCROSE ACETATE ISOBUTYRATE (cas 126-13-6). Pls Click Website Link as below: cas 126-13-6 suppliers

Prev:Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyImprovement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming SUCROSE ACETATE ISOBUTYRATE (cas 126-13-6) Depots
Next:Intracranial drug-delivery scaffolds: Biocompatibility evaluation of SUCROSE ACETATE ISOBUTYRATE (cas 126-13-6) gels)